Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Streamlining Utilization: HCA North Texas

Nine-hospital health system HCA North Texas, based in Irving, is like most health care organizations in the United States: faced with a challenging financial environment, it needs to find innovative ways to do more with less. Explains Michael Hayes, director of asset management for the health system, "We have to streamline processes that

Circ: Two hospital ranking methods found lacking

The two principal methods for ranking hospitals based on a composite performance measure for coronary artery disease (CAD) appear to be similarly capable of stratifying according to process of care, but neither showed a strong correlation with 30-day risk-standardized mortality or readmission rates, according to a study published Oct. 18 in Circulation: Cardiovascular Quality and Outcomes. The authors urged that more studies be done to better understand measures ability to discriminate quality.

Study: Racial disparities must be overcome with health IT

The U.S. healthcare system is not well designed to provide equitable care, as evidenced by the prevalence of disparities in care by race, ethnicity, language and social status, according to a study in the October issue of The Joint CommissionJournal on Quality and Patient Safety. As the United States invests in the design and implementation of health IT, consideration must be given to the impact that these innovations have on the quality and cost of healthcare for all patients, including those who experience disparities, wrote the study authors.

Report: 10 things to know about accountable care

Big changes were made on the ground level of accountable care organization (ACO) activity this week. While the final ACO rule was released Oct. 20, a report from the Institute for Health Technology Transformation released this week outlined generalizable ACO characteristics and recommendations to providers interested in applying for ACO status.

CMS releases participation revision for hospitals

The Centers for Medicare & Medicaid Services (CMS) could be flipping the script on the requirements that hospitals and critical access hospitals must meet to participate in the Medicare and Medicaid programs. The agency released a notice of proposed rulemaking stating that these proposed changes are an integral part of our efforts to reduce procedural burdens on providers.

CMS shifts policy on same-day surgeries at ambulatory centers

The Centers for Medicare & Medicaid Services (CMS) has released a final rule to revise the ambulatory surgical centers (ASCs) conditions for coverage to allow patient rights information to be provided to the patient, the patients representative or the patients surrogate prior to the start of the surgical procedure.

ACC expands PINNACLE registry to include AF patients

The American College of Cardiology (ACC) is expanding its outpatient registry, the PINNACLE Registry, with a new platform focusing on atrial fibrillation and including the next generation of anticoagulants.

AHA: Begin practice management changes now

Hospitals and health systems in the U.S. are facing an unparalleled force to change, according to the inaugural report of the American Hospital Association (AHA) Committee on Performance Improvement (CPI), which offered recommendations for practice management strategies for the healthcare environment of tomorrow.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.